Schroeder R, von Ahsen U, Belfort M
Wadworth Center for Laboratories and Research, New York State Department of Health, Albany 12201.
Biochemistry. 1991 Apr 2;30(13):3295-303. doi: 10.1021/bi00227a018.
The P7 element of group I introns contains a semiconserved "bulged" nucleotide, a C in group IA introns (nt 870 in the td intron) and an A in group IB introns [Cech, T.R. (1988) Gene 73, 259-271]. Variants U870, G870, and A870, isolated by a combination of in vitro and in vivo genetic strategies, indicate that C and A at position 870 are consistent with splicing whereas U and G are not. Although mutants G870 and U870 could be activated in vitro by increasing the Mg2+ concentration, their Km for GTP at pH 7 was 20-100-fold elevated, and they were unable to undergo site-specific hydrolysis. The dependence of the mutants on high guanosine concentrations could be substantially overcome by an increase in pH, suggesting that a tautomeric change, which makes U and G mimic C and A, is responsible for restoring function. In contrast to the striking Km effect, Vmax for the mutants differed by less than a factor of 2 from the wild type. Furthermore, streptomycin, an aminoglycoside antibiotic that competes with guanosine for its binding site, inhibited splicing of the U870 and G870 constructs at least as well as of the C870 and A870 variants, indicating that the guanosine-binding site of the mutants is proficient at interacting with a guanidino group. While our experiments argue against a hydrogen-bonding interaction between the C6-O of the cofactor and C4-NH2 of the bulged nucleotide, they are consistent with other models in which the C4-NH2 and/or N3 groups of the bulged C are involved in establishing an active ribozyme.
I 组内含子的P7元件包含一个半保守的“凸起”核苷酸,在IA组内含子中为C(td内含子中的第870位核苷酸),在IB组内含子中为A [切赫,T.R.(1988年)《基因》73卷,259 - 271页]。通过体外和体内遗传策略相结合分离出的变体U870、G870和A870表明,第870位的C和A与剪接一致,而U和G则不然。尽管突变体G870和U870可通过提高Mg2 +浓度在体外被激活,但其在pH 7时对GTP的Km值升高了20 - 100倍,且它们无法进行位点特异性水解。突变体对高鸟苷浓度的依赖性可通过提高pH值得到显著克服,这表明一种互变异构变化(使U和G模拟C和A)负责恢复功能。与显著的Km效应形成对比的是,突变体的Vmax与野生型的差异小于2倍。此外,链霉素是一种与鸟苷竞争其结合位点的氨基糖苷类抗生素,它对U870和G870构建体剪接的抑制作用至少与对C870和A870变体的抑制作用一样好,这表明突变体的鸟苷结合位点能够有效地与胍基相互作用。虽然我们的实验反对辅因子的C6 - O与凸起核苷酸的C4 - NH2之间存在氢键相互作用,但它们与其他模型一致,在这些模型中,凸起的C的C4 - NH2和/或N3基团参与形成活性核酶。